MTHFR rs1801133 polymorphism and susceptibility to colorectal cancer in Iranian population: evidence of a case-control study and meta-analysis

被引:7
作者
Haerian, Monir Sadat [1 ]
Haerian, Batoul Sadat [2 ]
Molanaei, Saadat [3 ]
Kosari, Farid [4 ]
Sabeti, Shahram [5 ]
Bidari-Zerehpoosh, Farahnaz [5 ]
Abdolali, Ebrahim [6 ]
Zali, Mohammad Reza [7 ]
机构
[1] Iran Univ Med Sci, Shafa Yahyaeian Orthoped Hosp, Bone & Joint Reconstruct Res Ctr, Tehran, Iran
[2] Shahid Beheshti Univ Med Sci, Fac Med, Tehran, Iran
[3] Milad Hosp, Dept Pathol, Tehran, Iran
[4] Univ Tehran Med Sci, Sina Hosp, Dept Pathol, Tehran, Iran
[5] Shahid Beheshti Univ Med Sci, Loghman Hakim Hosp, Dept Pathol, Tehran, Iran
[6] Shahid Beheshti Univ Med Sci, Taleghani Hosp, Dept Pathol, Tehran, Iran
[7] Shahid Beheshti Univ Med Sci, GLDRC, Tehran, Iran
关键词
colorectal cancer; meta-analysis; MTHFR; polymorphism; susceptibility; METHYLENETETRAHYDROFOLATE REDUCTASE C677T; A1298C POLYMORPHISMS; DNA-DAMAGE; RISK; FOLATE; ASSOCIATION; HOMOCYSTEINE; METHYLATION; DEFICIENCY; GENES;
D O I
10.2217/pgs-2016-0048
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Several studies have investigated whether MTHFR rs1801133 polymorphism contributes to risk of colorectal cancer (CRC), however the results are inconclusive. Aim: The purpose of this study was to investigate this hypothesis in a case-control study and meta-analysis in Iranian population. Materials & methods: This polymorphism was genotyped in the 2421 subjects (46% CRC patients) from Tehran. Meta-analysis was performed for determining the risk effect size of this polymorphism on CRC. Results: Both case-control study and meta-analysis showed no association between rs1801133 and CRC risk or its features. Conclusion: This study failed to identify an association between the rs1801133 and susceptibility to CRC in Iranian population.
引用
收藏
页码:1957 / 1965
页数:9
相关论文
共 41 条
[1]  
[Anonymous], 2006, BMC MED RES METHODOL, DOI DOI 10.1186/1471-2288-6-50
[2]   Folate Deficiency Induces Dysfunctional Long and Short Telomeres; Both States Are Associated with Hypomethylation and DNA Damage in Human WIL2-NS Cells [J].
Bull, Caroline F. ;
Mayrhofer, Graham ;
O'Callaghan, Nathan J. ;
Au, Amy Y. ;
Pickett, Hilda A. ;
Low, Grace Kah Mun ;
Zeegers, Dimphy ;
Hande, M. Prakash ;
Fenech, Michael F. .
CANCER PREVENTION RESEARCH, 2014, 7 (01) :128-138
[3]   Relationship between metabolic enzyme polymorphism and colorectal cancer [J].
Chen, Kun ;
Jiang, Qin-Ting ;
He, Han-Qing .
WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (03) :331-335
[4]   Folate and cancer: how DNA damage, repair and methylation impact on colon carcinogenesis [J].
Duthie, Susan J. .
JOURNAL OF INHERITED METABOLIC DISEASE, 2011, 34 (01) :101-109
[5]   5,10-Methylenetetrahydrofolate Reductase Polymorphisms and Colon Cancer Risk: a Meta-analysis [J].
Fang, Xin-Yu ;
Xu, Wang-Dong ;
Huang, Qian ;
Yang, Xiao-Ke ;
Liu, Yan-Yan ;
Leng, Rui-Xue ;
Pan, Hai-Feng ;
Ye, Dong-Qing .
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (19) :8245-8250
[6]   Folate (vitamin B9) and vitamin B12 and their function in the maintenance of nuclear and mitochondrial genome integrity [J].
Fenech, Michael .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2012, 733 (1-2) :21-33
[7]   Association of MTHFR C677T polymorphisms and colorectal cancer risk in Asians: evidence of 12,255 subjects [J].
Guo, X. -P. ;
Wang, Y. ;
Zhao, H. ;
Song, S. -D. ;
Zhou, J. ;
Han, Y. .
CLINICAL & TRANSLATIONAL ONCOLOGY, 2014, 16 (07) :623-629
[8]  
Haerian BS, 2015, PHARMACOGENOMICS, V16, P413, DOI [10.2217/PGS.14.177, 10.2217/pgs.14.177]
[9]   Association Between MTHFR Polymorphism (C677T) With Nonfamilial Colorectal Cancer [J].
Haghighi, Mahdi Montazer ;
Radpour, Ramin ;
Mahmoudi, Touraj ;
Mohebbi, Seyed Reza ;
Vahedi, Mohsen ;
Zali, Mohammad Reza .
ONCOLOGY RESEARCH, 2009, 18 (2-3) :57-63
[10]  
Hong Eun Pyo, 2012, Genomics & Informatics, V10, P117, DOI 10.5808/GI.2012.10.2.117